Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AHA: Nearly Half of U.S. Adults Have Cardiovascular Disease
THURSDAY, Jan. 31, 2019 (HealthDay News) — The prevalence of cardiovascular disease (CVD) is 48.0 percent in adults in the United States based on 2013 to 2016 data, according to a report published online Jan. 31 in Circulation.
E-Cigarettes More Effective for Smoking Cessation
THURSDAY, Jan. 31, 2019 (HealthDay News) — Electronic cigarettes are more effective for smoking cessation than nicotine replacement therapy, according to a study published online Jan. 30 in the New England Journal of Medicine.
Small Increase in HbA1c Seen With Switch to Human Insulin in T2DM
THURSDAY, Jan. 31, 2019 (HealthDay News) — Switching from analogue to human insulin is associated with a small increase in hemoglobin A1c (HbA1c) levels, according to a study published in the Jan. 29 issue of the Journal of the American Medical Association.
Meta-Analysis: Small Weight Increase Seen for Breakfast Eaters
THURSDAY, Jan. 31, 2019 (HealthDay News) — Eating breakfast may not be a good strategy for weight loss, according to research published online Jan. 30 in The BMJ.
FDA Receives an ‘F’ in Tobacco Prevention Report Card
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The U.S. Food and Drug Administration was given an “F” in a new American Lung Association report card evaluating tobacco prevention programs.
Avoiding Full-Blown Diabetes Cuts Cardiovascular Risk
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — Midlife increases in fasting glucose (FG) with conversion to diabetes are associated with higher cardiovascular disease (CVD) risk, according to research published online Jan. 7 in Diabetes Care.
Large Insulin Price Hike to Be Investigated by U.S. Congress
TUESDAY, Jan. 29, 2019 (HealthDay News) — The soaring cost of insulin will be investigated as the U.S. Congress holds hearings into the high cost of prescription drugs, a lawmaker says.
Few Patients With Type 1 Diabetes Meeting HbA1c Goals
TUESDAY, Jan. 29, 2019 (HealthDay News) — Only one in five children and adults with type 1 diabetes (T1D) in the United States achieve American Diabetes Association (ADA) goals for glycated hemoglobin (HbA1c), according to a study published online Jan. 18 in Diabetes Technology & Therapeutics.